| Literature DB >> 20431237 |
Ching-Feng Lin1, Shiing-Jer Twu, Ping-Ho Chen, Jror-Serk Cheng, Jung-Der Wang.
Abstract
BACKGROUND: The goal of this study was to determine the prevalence and risk factors for horizontal transmission of hepatitis B infection due to intravenous drug abuse (IVDA), tattooing, blood transfusion, and combinations of these risk factors.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20431237 PMCID: PMC3900846 DOI: 10.2188/jea.je20081045
Source DB: PubMed Journal: J Epidemiol ISSN: 0917-5040 Impact factor: 3.211
Frequency distributions and prevalence of HBsAg (%) stratified by demographic characteristics and major risk factors for horizontal transmission in Taiwanese inmates
| Major risk | No. of | No. of HBsAg(+) carriers/No. with a specific risk factor | VDRL(+) | |||
| Blood | Intravenous | Tattoo | Noneb | |||
| No. of Cases | 15 007 | 3333 | 3071 | 6908 | 5747 | 151 |
| (22.2) | (20.5) | (46.0) | (38.3) | (1.01) | ||
| HBsAg(+) | 3258 | 773 | 810 | 2022 | 737 | 33 |
| (21.7) | (23.2)a | (26.4)a | (29.3)a | (12.8) | (21.9) | |
| Age (years) | ||||||
| Mean | 29.73 | 30.47 | 32.17 | 27.66 | 26.72 | 33.00 |
| SD | 9.83 | 8.83 | 8.27 | 8.85 | 9.12 | 11.57 |
| 10–20 | 2850 | 97/445 | 39/150 | 290/1238 | 130/1089 | 25 |
| (21.8) | (26.0) | (23.4) | (11.9) | (0.88) | ||
| 21–30 | 5815 | 490/1296 | 454/1143 | 1239/3219 | 345/2224 | 50 |
| (37.8) | (39.7) | (38.5) | (15.5) | (0.86) | ||
| 31–40 | 3715 | 195/956 | 265/1175 | 366/1667 | 193/1427 | 34 |
| (20.4) | (22.6) | (22.0) | (13.5) | (0.92) | ||
| 41–50 | 1588 | 37/398 | 55/418 | 49/506 | 50/610 | 25 |
| (9.3) | (13.2) | (9.7) | (8.2) | (1.57) | ||
| ≥51 | 1039 | 14/238 | 17/185 | 17/278 | 19/397 | 17 |
| (5.9) | (9.2) | (6.1) | (4.8) | (1.64) | ||
| Sex | ||||||
| Male | 14 167 | 635/3191 | 680/2990 | 1373/6702 | 713/5425 | 104 |
| (19.9) | (22.7) | (20.5) | (13.1) | (0.73) | ||
| Female | 840 | 20/122 | 42/219 | 24/142 | 24/322 | 36 |
| (16.4) | (19.2) | (16.9) | (7.4) | (4.29) | ||
aP < 0.001 using crude chi-square test of association between individual risk factors and HBsAg(+).
bNo blood transfusion, intravenous drug abuse, or tattoo.
VDRL: Venereal disease research laboratory, HBsAg: hepatitis B surface antigen.
Adjusted odds ratios (aORs) and prevalence ratios (aPRs) with 95% CIs (confidence intervals) calculated using a multivariate regression model adjusted for age, gender, and major risk factors for horizontal transmission of Hepatitis B
| Risk factor | No. of HBsAg | Crude | aOR (95% CI) | aPR (95% CI) | ||
| Total | 3258/15 007 | 21.7% | ||||
| Age (years) | ||||||
| 10–20 | 699/2850 | 24.5% | 1.0 | 1.0 | ||
| 21–30 | 1299/5815 | 22.3% | 0.93 (0.81–1.05) | 0.94 (0.83–1.05) | ||
| 31–40 | 778/3715 | 20.9% | 0.84 (0.71–0.95) | 0.85 (0.72–0.97) | ||
| 41–50 | 295/1588 | 18.6% | 0.64 (0.49–0.76) | 0.65 (0.53–0.84) | ||
| ≥51 | 187/1039 | 18.0% | 0.45 (0.34–0.64) | 0.49 (0.36–0.69) | ||
| Sex (male/female) | 3109/14 167 | 21.9% | 1.69 (1.21–2.47) | 1.51 (1.12–2.37) | ||
| 149/840 | 17.6% | |||||
| Exposure: | ||||||
| Blood | IVDA | Tattoo | ||||
| − | − | − | 737/5747 | 12.8% | 1.0 | 1.0 |
| + | − | − | 266/1601 | 16.6% | 1.27 (1.05–1.61) | 1.22 (0.97–1.53) |
| − | + | − | 191/917 | 20.8% | 1.54 (1.27–1.86) | 1.45 (1.17–1.80) |
| − | − | + | 1070/3718 | 28.8% | 1.40 (1.23–1.55) | 1.33 (1.25–1.51) |
| + | + | − | 77/230 | 33.5% | 1.72 (1.57–1.97) | 1.60 (1.39–1.89) |
| + | − | + | 408/1105 | 36.9% | 1.69 (1.45–2.05) | 1.57 (1.28–1.91) |
| − | + | + | 392/1686 | 23.3% | 1.41 (1.21–1.64) | 1.35 (1.13–1.59) |
| + | + | + | 154/401 | 38.4% | 2.76 (2.20–3.47) | 2.30 (1.71–3.05) |
IVDA: intravenous drug abuse.
+: exposure, −: non-exposure.